Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Feb;37(2):269–281. doi: 10.1038/bjc.1978.36

Antitumour responses induced by short-term pretreatment with tumour cells.

K James, R T Cullen, I Milne, M Norval
PMCID: PMC2009583  PMID: 629863

Abstract

The injection (s.c. or i.p.) of 10(6) live or lethally irradiated methylcholanthrene-induced fibrosarcoma cells into CBA/Ca mice one or 2 days before i.v. challenge with the same tumour inhibited the formation of artificial lung tumour metastases. In addition, it also frequently enhanced the cytostatic effect of peritoneal exudate cells on monolayers of the same tumour. The effects on lung tumour metastasis were not noted if X-irradiated tumour was injected i.v., or if s.c. administration was delayed until one day after i.v. challenge. Similar effects on tumour growth were also observed in C3Hf/Bu mice and (CBA/Ca x A/HeJ) F1 hybrids which were pretreated (s.c.) with tumour shortly before i.v. challenge with the same tumour. Further studies in CBA/Ca mice suggested that the protective effect was tumour-specific, for the growth of i.v. injected tumour was not significantly inhibited by pretreatement with a number of other MC-induced or spontaneous tumours from the same and different strains.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonmassar E., Bonmassar A., Goldin A., Cudkowicz G. Depression of antilymphoma allograft reactivity by tumor-associated factors. Cancer Res. 1973 May;33(5):1054–1061. [PubMed] [Google Scholar]
  2. Bonnard G. D., Manders E. K., Campbell D. A., Jr, Herberman R. B., Collins M. J., Jr Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition. J Exp Med. 1976 Jan 1;143(1):187–205. doi: 10.1084/jem.143.1.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Carr I., Price P., Westby S. The effects of tumour extract on macrophage proliferation in lymph-nodes. J Pathol. 1976 Dec;120(4):251–254. doi: 10.1002/path.1711200408. [DOI] [PubMed] [Google Scholar]
  4. DeLustro F., Argyris B. F. Mastocytoma-medicated suppression of mixed lymphocyte culture and mitogen responsiveness. Cell Immunol. 1976 Jan;21(1):177–184. doi: 10.1016/0008-8749(76)90338-5. [DOI] [PubMed] [Google Scholar]
  5. Eccles S. A., Bandlow G., Alexander P. Monocytosis associated with the growth of transplanted syngeneic rat sarcomata differing in immunogenicity. Br J Cancer. 1976 Jul;34(1):20–27. doi: 10.1038/bjc.1976.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fujimoto S., Greene M. I., Sehon A. H. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):800–806. [PubMed] [Google Scholar]
  7. Ghaffar A., Cullen R. T., Dunbar N., Woodruff M. F. Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum. Br J Cancer. 1974 Mar;29(3):199–205. doi: 10.1038/bjc.1974.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kamo I., Patel C., Friedman H. Altered immunologic responsiveness in mastocytoma-bearing mice. J Natl Cancer Inst. 1976 Feb;56(2):333–338. doi: 10.1093/jnci/56.2.333. [DOI] [PubMed] [Google Scholar]
  9. Krahenbuhl J. L., Remington J. S. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells. J Immunol. 1974 Aug;113(2):507–516. [PubMed] [Google Scholar]
  10. Mackay J. M., Norval M., Robinson A., Tait D., Hart H., Marmion B. P., Muir A., Neill W. A. Cytology of rheumatoid synovial cells in culture. III. Significance of isolates of epithelial cell lines. Ann Rheum Dis. 1974 Sep;33(5):453–460. doi: 10.1136/ard.33.5.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Milas L., Hunter N., Mason K., Withers H. R. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 1974 Jan;34(1):61–71. [PubMed] [Google Scholar]
  12. Normann S. J., Sorkin E. Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro. Cancer Res. 1977 Mar;37(3):705–711. [PubMed] [Google Scholar]
  13. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Norval M., Marmion B. P. Attempts to identify viruses in rheumatoid synovial cells. Ann Rheum Dis. 1976 Apr;35(2):106–113. doi: 10.1136/ard.35.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pike M. C., Snyderman R. Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol. 1976 Oct;117(4):1243–1249. [PubMed] [Google Scholar]
  16. Prehn R. T. Do tumors grow because of the immune response of the host? Transplant Rev. 1976;28:34–42. doi: 10.1111/j.1600-065x.1976.tb00191.x. [DOI] [PubMed] [Google Scholar]
  17. Schick B., Berke G. Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells. J Immunol. 1977 Mar;118(3):986–991. [PubMed] [Google Scholar]
  18. Smith S. E., Scott M. T. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours. Br J Cancer. 1972 Oct;26(5):361–367. doi: 10.1038/bjc.1972.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Snyderman R., Pike M. C. An inhibitor of macrophage chemotaxis produced by neoplasms. Science. 1976 Apr 23;192(4237):370–372. doi: 10.1126/science.946556. [DOI] [PubMed] [Google Scholar]
  20. Suit H. D., Suchato C. Hyperbaric oxygen and radiotherapy of a fibrosarcoma and of a squamous-cell carcinoma of C3H mice. Radiology. 1967 Oct;89(4):713–719. doi: 10.1148/89.4.713. [DOI] [PubMed] [Google Scholar]
  21. Wong A., Mankovitz R., Kennedy J. C. Immunosuppressive and immunostimulatory factors produced by malignant cells in vitro. Int J Cancer. 1974 Apr 15;13(4):530–542. doi: 10.1002/ijc.2910130413. [DOI] [PubMed] [Google Scholar]
  22. Woodruff M. F., Boak J. L. Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer. 1966 Jun;20(2):345–355. doi: 10.1038/bjc.1966.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Woodruff M. F., Inchley M. P., Dunbar N. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours. Br J Cancer. 1972 Apr;26(2):67–76. doi: 10.1038/bjc.1972.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yuhas J. M., Pazmiño N. H., Wagner E. Development of concomitant immunity in mice bearing the weakly immunogenic line 1 lung carcinoma. Cancer Res. 1975 Jan;35(1):237–241. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES